Neuroprotective Agents with Therapeutic Potential for COVID-19

COVID-19 patients can exhibit a wide range of clinical manifestations affecting various organs and systems. Neurological symptoms have been reported in COVID-19 patients, both during the acute phase of the illness and in cases of long-term COVID. Moderate symptoms include ageusia, anosmia, altered m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaa, César A., Espitia, Clara, Reyes-Barrera, Karen L., An, Zhiqiang, Velasco-Velázquez, Marco A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669388/
https://www.ncbi.nlm.nih.gov/pubmed/38002267
http://dx.doi.org/10.3390/biom13111585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669388/
https://www.ncbi.nlm.nih.gov/pubmed/38002267
http://dx.doi.org/10.3390/biom13111585

Ejemplares similares